Evidence map›Paper›PMID 38970644›Full record

ArticlePsychopharmacology2024

Pulsed nicotine infusions as a model for smoking: validating a tool to explore nicotine thresholds in humans.

Suprit Parida, R Ross MacLean, Ralitza Gueorguieva, Mehmet Sofuoglu

Abstract readValidation Study
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Suprit ParidaDepartment of Psychiatry, School of Medicine, Yale University, New Haven, CT, USA.
R Ross MacLeanDepartment of Psychiatry, School of Medicine, Yale University, New Haven, CT, USA.
Ralitza GueorguievaDepartment of Biostatistics, Yale University School of Public Health, New Haven, CT, USA.
Mehmet SofuogluDepartment of Psychiatry, School of Medicine, Yale University, New Haven, CT, USA. Mehmet.sofoglu@yale.edu.ORCID http://orcid.org/0000-0002-5401-4681

Funding

U.S. Department of Veterans Affairs VISN 1 MIRECC
6 · The paper itself

Abstract

rationaleNo previous studies examined the discriminative stimulus effects of intravenous (IV) nicotine in humans.

objectivesTo evaluate a pulsed IV nicotine infusion procedure designed to mimic inhaled nicotine delivery and to identify a range of nicotine doses that may capture the threshold doses for the subjective and discriminative stimulus effects of nicotine. By determining these thresholds, we can gain valuable insights into the addictive threshold of nicotine.

methodsEleven participants had 2 Test Sessions following overnight abstinence from smoking. Test Session 1 examined participants' ability to discriminate 0.1 mg nicotine/pulse nicotine from saline. Test Session 2 examined if participants can discriminate 0.05, 0.025, and 0.0125 mg nicotine/pulse of nicotine from saline. These nicotine doses were delivered as a cluster of 4 pulsed-nicotine infusions of 2-second duration with a 28-second interval between each pulse.

resultsThe lowest doses of nicotine that produced greater responses than saline for discrimination, subjective effects, and heart rate ranged from 0.05 to 0.1 mg nicotine/pulse.

conclusionsThese findings support the validity of our pulsed-infusion procedure as a model for nicotine delivery by smoking and its utility in examining factors that may impact the addictive threshold of nicotine.

Indexed as

Dose-Response Relationship, DrugHeart RateNicotineAdultDiscrimination, PsychologicalFemaleHumansInfusions, IntravenousMaleNicotinic AgonistsSmokingYoung AdultNicotineNicotinic AgonistsNicotineNicotine discriminationNicotine reductionPulsed-infusion

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.